C
Clinical Research Center Medic-R | Poznan, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Pembrolizumab
Enfortumab
Cisplatin
MK-3475-905
Atogepant
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompa...
Enrolling
Chronic Migraine
Drug: Atogepant
Drug: Placebo for Atogepant
The purpose of this study is to assess the antitumor efficacy and safety of perioperative enfortumab vedotin (EV) plus pembrolizumab and radical cyst...
Active, not recruiting
Bladder Cancer
Biological: Enfortumab vedotin (EV)
Drug: Gemcitabine
This is a study of perioperative pembrolizumab or enfortumab vedotin in combination with pembrolizumab in participants who are cisplatin-ineligible o...
Active, not recruiting
Urinary Bladder Cancer, Muscle-invasive
Procedure: Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])
Drug: Pembrolizumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems